An NPS first for pharmacists
13 March 2012
NPS has launched its first online Pharmacy Practice Review, providing pharmacists with a new and convenient way to reflect on their practice and provide the latest evidence based advice to patients prescribed a statin and/or ezetimibe.
Building on the 2011 paper version of the activity, Pharmacy Practice Review: Reducing cardiovascular disease (CVD) risk pharmacists can now complete the activity online and immediately receive tailored feedback and individual patient management plans to support ongoing care for their patients.
NPS Clinical Adviser Dr Danielle Stowasser says that this online activity is a first for NPS and sets the benchmark for a whole suite of online professional development activities for health professionals to come.
"We are excited to be working more and more in the online space and to be providing pharmacists with the flexibility and individualisation that online activities can offer," says Dr Stowasser.
The activity gives pharmacists access to the latest evidence-based clinical information on cardiovascular disease risk and optimal use of statins, and where indicated, ezetimibe.
By reflecting on 10 episodes of care, pharmacists can plan actions for their ongoing patient management and identify areas for their own practice improvement based on best practice standards, guidelines and competencies.
"The changing environment of pharmacy is seeing more pharmacists take part in patient education, screening and monitoring of conditions, lifestyle modification and medicines adherence," says Dr Stowasser.
"The Pharmacy Practice Review helps foster these behaviours and instils more confidence in pharmacists when providing advice to patients with or at risk of cardiovascular disease."
Other benefits for pharmacists participating in the new online activity include:
- comparison with peer group results
- access to expert commentary
- immediate availability of a completion certificate so pharmacists can log their CPD points; and
- access to the activity on an ongoing basis so pharmacists can continue to reflect on their encounters with patients using statins and/or ezetimibe.
"We urge pharmacists to register for the online NPS Pharmacy Practice Review and see for themselves what a valuable investment of their time it is," says Dr Stowasser.
The activity is free and accredited as a Group 2 activity for 16 credit points.
To register for Pharmacy Practice Review: Reducing CVD risk, visit www.nps.org.au/ppr_cvd
For further information, contact Le Moss on 02 8217 8700 (select option 2) or email email@example.com
Independent, evidence-based and not-for-profit, NPS enables better decisions about medicines and medical tests.We are funded by the Australian Government Department of Health and Ageing.